| Financial Year |
March 31 2023 |
| Monetary Funds |
5,971,813,113.00 |
| Held-for-trading Financial Assets |
986,376,468.00 |
| Notes Receivable |
1,738,466,620.00 |
| Accounts Receivable |
1,506,207,006.00 |
| Advances to Suppliers |
968,019,791.00 |
| Other Receivables |
576,478,678.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,334,545,549.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,264,620,672.00 |
| Total Current Assets |
35,378,821,167.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,475,660,182.00 |
| Investment Properties |
56,705,103.00 |
| Fixed Assetes |
42,074,777,690.00 |
| Under-construction Projects |
9,033,287,045.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,835,461,098.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
148,011,417.00 |
| Other Non-Current Assets |
4,049,289.00 |
| Sub-Total of Non-Current Assets |
58,365,432,795.00 |
| Total Assets |
93,744,253,962.00 |
| Short-Term Loans |
5,937,004,337.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,151,172,308.00 |
| Accounts Payable |
18,402,673,159.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
158,453,789.00 |
| Taxes Payable |
638,891,879.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,982,180,623.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,577,761,538.00 |
| Other Current Liabilities |
658,833,578.00 |
| Sub-Total of Current Liabilities |
52,096,678,210.00 |
| Long-term Loans |
7,532,322,425.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
167,595,940.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,397,498.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,932,921,349.00 |
| Total Liabilities |
61,029,599,559.00 |
| Paid-In Capital(Or Share Stock) |
7,773,867,186.00 |
| Capital Surplus |
8,440,353,292.00 |
| Surplus Reserve |
4,720,262,453.00 |
| LESS:Treasury Stock |
167,595,940.00 |
| Undistributed Profits |
7,569,603,944.00 |
| Minority Stockholder's Interest |
4,059,800,581.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,654,853,822.00 |
| Owner's Equity（Stockholder's Equity） |
32,714,654,403.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
93,744,253,962.00 |
